| ISIN | LU2319669359 |
|---|---|
| Valor Number | 110410156 |
| Bloomberg Global ID | |
| Fund Name | Pictet - Longevity HZ CHF |
| Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
| Fund Provider | Pictet Asset Management S.A. |
| Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
| Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The investment objective of the fund is to increase the value of your investment while seeking to achieve a positive social impact. The Fund aims to achieve long-term capital growth by investing in companies that support and enhance longevity, as it pertains to individuals and society. |
| Peculiarities |
| Current Price * | 380.07 CHF | 04.12.2025 |
|---|---|---|
| Previous Price * | 379.02 CHF | 03.12.2025 |
| 52 Week High * | 428.32 CHF | 07.02.2025 |
| 52 Week Low * | 345.66 CHF | 07.04.2025 |
| NAV * | 380.07 CHF | 04.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 418,843,032 | |
| Unit/Share Assets *** | 61,079 | |
| Trading Information SIX | ||
| YTD Performance | -5.13% |
31.12.2024 - 04.12.2025
31.12.2024 04.12.2025 |
|---|---|---|
| 1 month | +2.72% |
04.11.2025 - 04.12.2025
04.11.2025 04.12.2025 |
| 3 months | +1.21% |
04.09.2025 - 04.12.2025
04.09.2025 04.12.2025 |
| 6 months | -2.53% |
04.06.2025 - 04.12.2025
04.06.2025 04.12.2025 |
| 1 year | -9.08% |
04.12.2024 - 04.12.2025
04.12.2024 04.12.2025 |
| 2 years | +1.24% |
04.12.2023 - 04.12.2025
04.12.2023 04.12.2025 |
| 3 years | -0.26% |
05.12.2022 - 04.12.2025
05.12.2022 04.12.2025 |
| 5 years | -15.12% |
14.06.2021 - 04.12.2025
14.06.2021 04.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Boston Scientific Corp | 7.20% | |
|---|---|---|
| Intuitive Surgical Inc | 5.53% | |
| Lonza Group Ltd | 5.46% | |
| Danaher Corp | 5.34% | |
| AstraZeneca PLC | 4.94% | |
| Eli Lilly and Co | 4.74% | |
| Agilent Technologies Inc | 4.45% | |
| Garmin Ltd | 4.09% | |
| Steris PLC | 3.93% | |
| Haleon PLC | 3.68% | |
| Last data update | 31.10.2025 | |
| TER *** | 0.18% |
|---|---|
| TER date *** | 31.03.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.00% |
| Ongoing Charges *** | 0.16% |
|
SRRI ***
|
|
| SRRI date *** | 31.07.2021 |